HealthyDirect · GrowthFit for a long SIP
Axis Crisil IBX 50:50 Gilt Plus SDL September 2027 Index Fund
- NAV
- 12.9938
- 29 Oct 2026
- 1Y
- +5.1%
- Trailing CAGR
- AUM
- ₹36.26 Cr
- 30 Sept 2026
- Volatility
- Low
- 0.9% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · Three-year return is above the category median.
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Buy checklist
History depth
Watch
3.7 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.15% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -0.4%. Ask whether you can hold through a similar fall.
Vs category
Fail
20% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 98.6% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 0%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+5.1%
- 3Y+7.4%
- 5Yn/a
- 10Yn/a
- SI+7.4%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+4.8%
- 3Y+6.5%
- 5Yn/a
- 10Yn/a
- Since inception
- +7.4%
- Calendar-day CAGR
- Excess 1Y
- +0.1%
- Category median, same plan and option
- 3Y win rate
- +20%
- Windows beating the median
- 3Y percentile
- 62
- Vs comparable share classes
- SIP 3Y XIRR
- +6.5%
- Simulated monthly SIP
- Worst rolling 3Y
- +7.1%
- 162 daily-ending windows
- Median rolling 3Y
- +7.4%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -0.4%
- Worst peak-to-trough
- Current
- -0.0%
- Below last peak
- Current spell
- 16 days
- Days below latest peak
- Time below peak
- +38%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 3 days
- 137 recovered episodes
- Longest recovery
- 18 days
- Trough to prior peak
27 Sept 2023 – 27 Oct 2023
Trough 9 Oct 2023 · recovered in 18 days
-0.4%
31 Mar 2026 – 8 Apr 2026
Trough 2 Apr 2026 · recovered in 6 days
-0.3%
24 Jul 2023 – 21 Aug 2023
Trough 3 Aug 2023 · recovered in 18 days
-0.3%
13 Oct 2026 – open
Trough 16 Oct 2026 · not recovered
-0.2%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
62
Vs category
51
Consistency
20
Risk-adjusted
100
Drawdown
99
Mean
66
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 11 holdings · top 10 are 98.6%.
- Top 5
- 87.6%
- Top 10
- 98.6%
- Largest holding
- 47.3%
- Effective holdings
- 3.2
GOVERNMENT OF INDIA 31719 GOI 20JU27 7.38 FV RS 100
Entities
47.3%
STATE DEVELOPMENT LOAN 19792 MH 13SP27 7.33 FV RS 100
Unspecified
27.8%
Tamilnadu State SDL 7.23 14/06/2027
Unspecified
6.9%
9. 7.45% RAJASTHAN SDL 27/09/2027
Unspecified
2.8%
STATE DEVELOPMENT LOAN 19636 TN 28JU27 7.24 FV RS 100
Unspecified
2.8%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Axis CRISIL-IBX Financial Services 3-6 Months Debt Index Fund
Axis Mutual Fund
- 1Y
- +6.5%
- 3Y
- n/a
- Vol
- 0.4%
- Max DD
- -0.1%
- Sharpe
- 1.39
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
Caveat: Lower trailing returns
Mirae Asset CRISIL-IBX Financial Services 9-12 Months Debt Index Fund
Mirae Asset Mutual Fund
- 1Y
- +5.9%
- 3Y
- n/a
- Vol
- 0.6%
- Max DD
- -0.2%
- Sharpe
- 0.23
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
Caveat: Lower trailing returns
Axis CRISIL-IBX AAA Bond Financial Services - Sep 2027 Index Fund
Axis Mutual Fund
- 1Y
- +6.1%
- 3Y
- n/a
- Vol
- 0.8%
- Max DD
- -0.4%
- Sharpe
- 1.65
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
Axis CRISIL-IBX AAA Bond NBFC - Jun 2027 Index Fund
Axis Mutual Fund
- 1Y
- +6.1%
- 3Y
- n/a
- Vol
- 0.8%
- Max DD
- -0.3%
- Sharpe
- 1.94
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Lower trailing returns
Axis CRISIL-IBX AAA Bond NBFC-HFC - Jun 2027 Index Fund
Axis Mutual Fund
- 1Y
- +6.3%
- 3Y
- n/a
- Vol
- 0.8%
- Max DD
- -0.3%
- Sharpe
- 1.82
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns